iShares NASDAQ Biotechnology Index shares owned by Shepherd Financial Partners
Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Shepherd Financial Partners
from 13F filings
Historical chart of Shepherd Financial Partners investment in iShares NASDAQ Biotechnology Index
Tip: Access up to 7 years of quarterly data
All positions including iShares NASDAQ Biotechnology Index held by Shepherd Financial Partners consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in iShares NASDAQ Biotechnology Index by Shepherd Financial Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $213k | 1.3k | 168.77 |
| 2025-03-31 | $863k | 6.7k | 127.90 |
| 2024-12-31 | $859k | 6.5k | 132.20 |
| 2024-09-30 | $939k | 6.4k | 145.61 |
| 2024-06-30 | $880k | 6.4k | 137.26 |
| 2024-03-31 | $876k | 6.4k | 137.19 |
| 2023-12-31 | $866k | 6.4k | 135.86 |
| 2022-12-31 | $268k | 2.0k | 131.25 |
| 2022-09-30 | $244k | 2.1k | 116.91 |
| 2022-06-30 | $273k | 2.3k | 117.62 |
| 2022-03-31 | $999k | 7.7k | 129.89 |
| 2021-12-31 | $1.2M | 8.0k | 152.49 |
| 2021-09-30 | $1.3M | 7.9k | 161.41 |
| 2021-06-30 | $1.3M | 7.8k | 163.67 |
| 2021-03-31 | $994k | 6.6k | 150.51 |
| 2020-12-31 | $978k | 6.4k | 151.67 |
| 2020-09-30 | $840k | 6.1k | 136.65 |
| 2020-06-30 | $840k | 6.1k | 136.65 |
| 2020-03-31 | $648k | 6.0k | 107.84 |
| 2019-12-31 | $830k | 6.9k | 120.67 |
| 2019-09-30 | $686k | 6.9k | 99.74 |
| 2019-06-30 | $794k | 7.3k | 109.07 |
| 2019-03-31 | $814k | 7.3k | 111.81 |
| 2018-12-31 | $400k | 4.2k | 95.53 |
| 2018-09-30 | $1.3M | 12k | 109.58 |
| 2018-06-30 | $1.3M | 12k | 110.57 |
| 2018-03-31 | $1.1M | 10k | 106.60 |
| 2017-12-31 | $1.1M | 11k | 107.40 |
| 2017-09-30 | $767k | 2.3k | 338.18 |
| 2017-06-30 | $436k | 1.4k | 308.35 |
More positions owned by Shepherd Financial Partners
View all positions for Shepherd Financial Partners
Top funds holding iShares NASDAQ Biotechnology Index
View all funds holding iShares NASDAQ Biotechnology Index